KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Total Current Liabilities (2016 - 2025)

Quest Diagnostics' Total Current Liabilities history spans 17 years, with the latest figure at $2.3 billion for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 5.03% year-over-year to $2.3 billion; the TTM value through Dec 2025 reached $2.3 billion, up 5.03%, while the annual FY2025 figure was $2.3 billion, 5.03% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $2.3 billion at Quest Diagnostics, up from $2.1 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $2.3 billion in Q1 2024 and bottomed at $1.4 billion in Q1 2023.
  • The 5-year median for Total Current Liabilities is $1.8 billion (2021), against an average of $1.8 billion.
  • The largest annual shift saw Total Current Liabilities soared 69.59% in 2024 before it plummeted 37.29% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $1.8 billion in 2021, then decreased by 11.52% to $1.6 billion in 2022, then increased by 17.02% to $1.8 billion in 2023, then grew by 19.5% to $2.2 billion in 2024, then rose by 5.03% to $2.3 billion in 2025.
  • Per Business Quant, the three most recent readings for DGX's Total Current Liabilities are $2.3 billion (Q4 2025), $2.1 billion (Q3 2025), and $2.0 billion (Q2 2025).